Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 31,522 | 26,759 | 21,646 | 18,717 | 18,958 |
| Cost of Goods | 16,167 | 13,490 | 10,626 | 9,217 | 9,885 |
| Gross Profit | 15,355 | 13,269 | 11,020 | 9,500 | 9,073 |
| Operating Expenses | 15,904 | 15,025 | 11,272 | 10,107 | 10,227 |
| Operating Income | -382 | -1,266 | 374 | -390 | -269 |
| Interest Expense | 1,483 | 894 | 181 | 189 | 180 |
| Other Income | -2 | -3,085 | -668 | -85 | -283 |
| Pre-tax Income | -1,867 | -5,245 | -475 | -664 | -732 |
| Income Tax | -369 | 605 | -464 | -19 | -115 |
| Net Income Continuous | -1,498 | -5,850 | -11 | -645 | -617 |
| Net Income Discontinuous | 34 | 1,786 | 1,010 | 228 | 236 |
| Net Income | $-1,464 | $-4,064 | $999 | $-417 | $-381 |
| EPS Basic Total Ops | -0.40 | -1.10 | 0.30 | -0.10 | -0.10 |
| EPS Basic Continuous Ops | -0.40 | -1.60 | N/A | -0.20 | -0.20 |
| EPS Basic Discontinuous Ops | 0.01 | 0.50 | 0.20 | 0.10 | 0.10 |
| EPS Diluted Total Ops | -0.40 | -1.10 | 0.30 | -0.10 | -0.10 |
| EPS Diluted Continuous Ops | -0.40 | -1.60 | N/A | -0.20 | -0.20 |
| EPS Diluted Discontinuous Ops | 0.01 | 0.50 | 0.20 | 0.10 | 0.10 |
| EBITDA(a) | $1,776 | $661 | $1,318 | $600 | $709 |